Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Swannington Enterprises Ltd investment portfolio

Swannington Enterprises Ltd has made numerous investments in companies such as Tern Technologies, Genome Therapeutics, and Tympa Health Technologies within the Healthcare & Life Sciences sector.

university
Portfolio
3
Team
0

Ownership Chain

Sign up free to see the Persons with Significant Control resolved from Companies House.

Sign up free

Portfolio (3)

CompanySectorCitySourceLast confirmed on
Genome Therapeutics Ltd
Genome Therapeutics Ltd develops novel chemical compounds, such as tetracyclic and quinolone derivatives, for use in antibody‑drug conjugates and other cancer‑targeted therapies. Its products are aimed at the pharmaceutical and biotechnology markets focused on oncology.
Healthcare & Life SciencesLondonConfirmed2026-01-07
Tern Technologies Ltd
Tern Technologies Ltd operates an AI‑powered platform that recruits and relocates healthcare professionals for hospitals and health systems worldwide, providing end‑to‑end hiring and relocation services to streamline international talent acquisition in the healthcare sector.
Software & ITLondonConfirmed2025-11-28

Sign up to see the full portfolio

+1 more company

Sign up

Shareholding changes (2)

Sign up free to see when this investor has bought or sold shares.

Sign up free